Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04436731Phase 1Active, not recruiting
Phase 1, open-label, single-arm trial, sponsored by University of Missouri. Primary endpoint: Change in forearm vascular conductance. Started Dec 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04436731.